Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors

Clinical trial NCT05234853 · UNKNOWN

Trial details

NCT number: NCT05234853
Sponsor: Purinomia Biotech, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-04-28
Primary completion: 2023-12-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.